Superworth

Kewaunee Scientific PE ratio KEQU

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026
11.9×
10-year median
13.7×
Against its 10-year history
36th
percentile: 0 is its lowest day, 100 its highest
10-year range
5.1× to 84.5×
Peer median
21.9×

Kewaunee Scientific's PE ratio is 11.9× as of Oct 23, 2026: a share price of $32.79 against $2.76 of earnings per share over the last twelve months.

That is below its ten-year median of 13.7×, close to the middle of its last ten years.

Over that time it ranged from 5.1× in Oct 2024 to 84.5× in Dec 2019.

The median for 9 medical instruments and supplies stocks of a similar size is 21.9×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far11.9×9.1×12.5×
20259.6×5.3×15.4×
202410.1×5.1×14.4×
202312.2×9.2×65.3×
2022n/m a value too high to mean anything
2021n/m a value too high to mean anything
2020n/m a value too high to mean anything
201984.5×11.8×84.5×
201815.9×11.6×19.3×
201717.2×12.4×19.1×
201613.4×13.4×18.3×
201517.4×11.2×17.4×
201411.7×10.1×13.7×
20139.9×9.7×13.9×
201212.9×12.8×32.5×

Against its peers

Companies in Medical - Instruments & Supplies nearest Kewaunee Scientific's size, closest first, today.

CompanyPE ratio
KEQUKewaunee Scientific11.9×
APTAlpha Pro Tech13.6×
PDEXPro DEX15.1×
NEPHNephros22.1×
UTMDUtah Medical Products22.6×
INFUInfuSystem34.0×
EMBCEmbecta4.6×
TCMDTactile Systems Technology21.9×
MDXGMimedx97.8×
MOVMovado17.5×
Peer median21.9×

Where Kewaunee Scientific ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Kewaunee Scientific

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.